Detalhe da pesquisa
1.
Tolerogenic IL-10-engineered dendritic cell-based therapy to restore antigen-specific tolerance in T cell mediated diseases.
J Autoimmun
; 138: 103051, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37224733
2.
Engineered type 1 regulatory T cells designed for clinical use kill primary pediatric acute myeloid leukemia cells.
Haematologica
; 106(10): 2588-2597, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33054128
3.
IL-10-Engineered Human CD4+ Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism.
Mol Ther
; 32(3): 853-854, 2024 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38359840
4.
IL-10-Engineered Human CD4+ Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism.
Mol Ther
; 25(10): 2254-2269, 2017 10 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28807569
5.
Enforced IL-10 expression confers type 1 regulatory T cell (Tr1) phenotype and function to human CD4(+) T cells.
Mol Ther
; 20(9): 1778-90, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22692497
6.
Aryl hydrocarbon receptor activity downstream of IL-10 signaling is required to promote regulatory functions in human dendritic cells.
Cell Rep
; 42(3): 112193, 2023 03 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36870061
7.
Constitutive IL-1RA production by modified immune cells protects against IL-1-mediated inflammatory disorders.
Sci Transl Med
; 15(698): eade3856, 2023 05 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37256935
8.
Gene therapy for immunodeficiency due to adenosine deaminase deficiency.
N Engl J Med
; 360(5): 447-58, 2009 Jan 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-19179314
9.
Corrigendum: Generation of Powerful Human Tolerogenic Dendritic Cells by Lentiviral-Mediated IL-10 Gene Transfer.
Front Immunol
; 12: 672701, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33828568
10.
Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy.
J Clin Invest
; 117(8): 2233-40, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17671653
11.
Generation of Powerful Human Tolerogenic Dendritic Cells by Lentiviral-Mediated IL-10 Gene Transfer.
Front Immunol
; 11: 1260, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32695103
12.
Impaired humoral immunity in X-linked lymphoproliferative disease is associated with defective IL-10 production by CD4+ T cells.
J Clin Invest
; 115(4): 1049-59, 2005 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15761493
13.
Immune reconstitution in ADA-SCID after PBL gene therapy and discontinuation of enzyme replacement.
Nat Med
; 8(5): 423-5, 2002 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-11984564
14.
Innate-like effector differentiation of human invariant NKT cells driven by IL-7.
J Immunol
; 180(7): 4415-24, 2008 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18354162
15.
SAP controls the cytolytic activity of CD8+ T cells against EBV-infected cells.
Blood
; 105(11): 4383-9, 2005 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15677558
16.
Bone marrow clonogenic capability, cytokine production, and thymic output in patients with common variable immunodeficiency.
J Immunol
; 174(8): 5074-81, 2005 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15817443
17.
IL-3 or IL-7 increases ex vivo gene transfer efficiency in ADA-SCID BM CD34+ cells while maintaining in vivo lymphoid potential.
Mol Ther
; 10(6): 1096-108, 2004 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-15564141
18.
X-linked Opitz syndrome: novel mutations in the MID1 gene and redefinition of the clinical spectrum.
Am J Med Genet A
; 120A(2): 222-8, 2003 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12833403
19.
Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning.
Science
; 296(5577): 2410-3, 2002 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-12089448